Geode Capital Management’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Sell |
245,665
-321,317
| -57% | -$418K | ﹤0.01% | 3712 |
|
|
2025
Q1 | $788K | Buy |
566,982
+1,493
| +0.3% | +$2.08K | ﹤0.01% | 3387 |
|
|
2024
Q4 | $1.3M | Buy |
565,489
+3,880
| +0.7% | +$8.89K | ﹤0.01% | 3269 |
|
|
2024
Q3 | $1.53M | Sell |
561,609
-514
| -0.1% | -$1.4K | ﹤0.01% | 3208 |
|
|
2024
Q2 | $1.32M | Buy |
562,123
+48,074
| +9% | +$113K | ﹤0.01% | 3212 |
|
|
2024
Q1 | $2.41M | Buy |
514,049
+15,874
| +3% | +$74.5K | ﹤0.01% | 3045 |
|
|
2023
Q4 | $2.43M | Buy |
498,175
+32,094
| +7% | +$157K | ﹤0.01% | 3031 |
|
|
2023
Q3 | $2.17M | Buy |
466,081
+99,465
| +27% | +$463K | ﹤0.01% | 3052 |
|
|
2023
Q2 | $2.71M | Buy |
366,616
+44,577
| +14% | +$329K | ﹤0.01% | 3014 |
|
|
2023
Q1 | $2.63M | Buy |
322,039
+14,904
| +5% | +$122K | ﹤0.01% | 2917 |
|
|
2022
Q4 | $2.94M | Buy |
307,135
+6,235
| +2% | +$59.7K | ﹤0.01% | 2907 |
|
|
2022
Q3 | $3.54M | Buy |
300,900
+111,119
| +59% | +$1.31M | ﹤0.01% | 2864 |
|
|
2022
Q2 | $2.44M | Buy |
189,781
+580
| +0.3% | +$7.45K | ﹤0.01% | 3046 |
|
|
2022
Q1 | $2.08M | Buy |
189,201
+5,986
| +3% | +$65.8K | ﹤0.01% | 3239 |
|
|
2021
Q4 | $2.81M | Buy |
183,215
+49,443
| +37% | +$757K | ﹤0.01% | 3200 |
|
|
2021
Q3 | $1.87M | Buy |
133,772
+8,074
| +6% | +$113K | ﹤0.01% | 3378 |
|
|
2021
Q2 | $2.43M | Buy |
+125,698
| New | +$2.43M | ﹤0.01% | 3203 |
|